Literature DB >> 10729297

No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis.

M McKibbin1, B Clark, H Lee, J D Isaacs, H C Gooi, A J Morrell.   

Abstract

AIMS: To investigate polymorphism within the tumour necrosis factor alpha (TNF-alpha) promoter region and within the interleukin-1 receptor antagonist (IL-1Ra) gene in a group of patients with vasculitis associated corneal melting.
METHODS: The polymorphic regions at position -308 on the TNF-alpha promoter region and in intron 2 of the IL-1Ra gene were amplified by the polymerase chain reaction (PCR). The resultant products were separated by electrophoresis on agarose gels and visualised by ethidium bromide staining. Genotype and allele frequencies for the 20 patients were compared with healthy controls from the same geographical area.
RESULTS: The allele frequencies in the patient and control groups respectively for the TNF-alpha and IL-1Ra sites studied were as follows: TNF1, 82.5% and 80.2%; TNF2, 17.5% and 19.8%; IL-1Ra*1, 82. 5% and 78.3%; IL-1Ra*2, 15% and 20%; IL-1Ra*3 2.5% and 1.5%. Although there was a trend for the IL1Ra*2 allele to be more common in the control group, no allele was found to have a statistically significantly association with the patient group: TNF1 p = 0.89; TNF2 p = 0.89; IL-1Ra*1 p = 0.65; IL-1Ra*2 p = 0.68; IL-1Ra*3 p= 0. 50.
CONCLUSIONS: The results suggest that the polymorphic alleles of TNF-alpha and IL-1Ra studied play little or no part in the susceptibility to corneal melting among these patients with systemic vasculitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729297      PMCID: PMC1723444          DOI: 10.1136/bjo.84.4.395

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  33 in total

1.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.

Authors:  A G Wilson; F S di Giovine; A I Blakemore; G W Duff
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

2.  An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis.

Authors:  J Tauber; M Sainz de la Maza; T Hoang-Xuan; C S Foster
Journal:  Cornea       Date:  1990-01       Impact factor: 2.651

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Vascular changes in peripheral corneal destructive disease.

Authors:  P G Watson
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

5.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat.

Authors:  J K Tarlow; A I Blakemore; A Lennard; R Solari; H N Hughes; A Steinkasserer; G W Duff
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

6.  Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis.

Authors:  G S Firestein; D L Boyle; C Yu; M M Paine; T D Whisenand; N J Zvaifler; W P Arend
Journal:  Arthritis Rheum       Date:  1994-05

7.  Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus.

Authors:  A I Blakemore; J K Tarlow; M J Cork; C Gordon; P Emery; G W Duff
Journal:  Arthritis Rheum       Date:  1994-09

8.  Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.

Authors:  M C Kennedy; J T Rosenbaum; J Brown; S R Planck; X Huang; C A Armstrong; J C Ansel
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

9.  Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

Authors:  C S Foster; S L Forstot; L A Wilson
Journal:  Ophthalmology       Date:  1984-10       Impact factor: 12.079

10.  Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy.

Authors:  G N Kervick; S C Pflugfelder; R Haimovici; H Brown; E Tozman; R Yee
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.